Literature DB >> 12080348

Nucleophosmin regulates the stability and transcriptional activity of p53.

Emanuela Colombo1, Jean-Christophe Marine, Davide Danovi, Brunangelo Falini, Pier Giuseppe Pelicci.   

Abstract

Nucleophosmin (NPM) is a ubiquitously expressed nucleolar phosphoprotein that continuously shuttles between the nucleus and cytoplasm. It has been proposed to function in ribosomal protein assembly and transport, and also as a molecular chaperone that prevents proteins from aggregating in the crowded environment of the nucleolus. The NPM gene is involved in several tumour-associated chromosome translocations, which have resulted in the formation of fusion proteins that retain the amino terminus of NPM, including NPM ALK, NPM RAR and NPM MLF1 (ref. 6). It is generally thought that the NPM component is not involved in the transforming potential of these fusion proteins, but instead provides a dimerization interface for the oligomerization and the oncogenic conversion of the various NPM partners (ALK, RAR, MLF1). Here we show that NPM interacts directly with the tumour suppressor p53, regulates the increase in stability and transcriptional activation of p53 after different types of stress, and induces p53-dependent premature senescence on overexpression in diploid fibroblasts. These findings indicate that NPM is a crucial regulator of p53 and suggest that alterations of the NPM function by NPM fusion proteins might lead to deregulation of p53 in tumours.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12080348     DOI: 10.1038/ncb814

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  177 in total

1.  AKT-dependent phosphorylation of Niban regulates nucleophosmin- and MDM2-mediated p53 stability and cell apoptosis.

Authors:  Haitao Ji; Zhiyong Ding; David Hawke; Dongming Xing; Bing-Hua Jiang; Gordon B Mills; Zhimin Lu
Journal:  EMBO Rep       Date:  2012-06-01       Impact factor: 8.807

2.  The leukemic oncoprotein NPM1-RARA inhibits TP53 activity.

Authors:  Erin M Swaney; Anuja Chattopadhyay; Irina Abecassis; Elizabeth A Rush; Robert L Redner
Journal:  Leuk Lymphoma       Date:  2016-01-12

Review 3.  Nucleophosmin and human cancer.

Authors:  Mi Jung Lim; Xin Wei Wang
Journal:  Cancer Detect Prev       Date:  2006-11-17

Review 4.  Biology, clinical relevance, and molecularly targeted therapy in acute leukemia with FLT3 mutation.

Authors:  Hitoshi Kiyoi; Tomoki Naoe
Journal:  Int J Hematol       Date:  2006-05       Impact factor: 2.490

Review 5.  The moving parts of the nucleolus.

Authors:  M O J Olson; Miroslav Dundr
Journal:  Histochem Cell Biol       Date:  2005-03-02       Impact factor: 4.304

6.  Nucleophosmin contributes to the transcriptional activation function of the Epstein-Barr virus EBNA1 protein.

Authors:  Natasha Malik-Soni; Lori Frappier
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

7.  Identification of nucleophosmin as an NF-kappaB co-activator for the induction of the human SOD2 gene.

Authors:  Sanjit K Dhar; Bert C Lynn; Chotiros Daosukho; Daret K St Clair
Journal:  J Biol Chem       Date:  2004-04-15       Impact factor: 5.157

8.  Nucleophosmin sets a threshold for p53 response to UV radiation.

Authors:  Dony A Maiguel; Leslie Jones; Devulapalli Chakravarty; Chonglin Yang; France Carrier
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

9.  Human histone chaperone nucleophosmin enhances acetylation-dependent chromatin transcription.

Authors:  V Swaminathan; A Hari Kishore; K K Febitha; Tapas K Kundu
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

10.  Human rpL3 induces G₁/S arrest or apoptosis by modulating p21 (waf1/cip1) levels in a p53-independent manner.

Authors:  Annapina Russo; Davide Esposito; Morena Catillo; Concetta Pietropaolo; Elvira Crescenzi; Giulia Russo
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.